CATALOGO DEI PRODOTTI DELLA RICERCA

ADAMI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.099
NA - Nord America 2.012
AS - Asia 1.286
AF - Africa 34
SA - Sud America 7
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.444
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.002
CN - Cina 775
GB - Regno Unito 458
SG - Singapore 384
RU - Federazione Russa 346
IT - Italia 296
DE - Germania 229
SE - Svezia 223
IE - Irlanda 214
FR - Francia 192
FI - Finlandia 60
JP - Giappone 37
TG - Togo 27
UA - Ucraina 20
KR - Corea 15
NL - Olanda 15
TR - Turchia 14
VN - Vietnam 14
ID - Indonesia 13
HK - Hong Kong 12
CA - Canada 10
AT - Austria 9
BE - Belgio 7
PT - Portogallo 7
IR - Iran 6
CH - Svizzera 5
ZA - Sudafrica 5
IN - India 4
AU - Australia 3
BR - Brasile 3
GR - Grecia 3
LV - Lettonia 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CY - Cipro 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
FK - Isole Falkland (Malvinas) 1
HR - Croazia 1
IQ - Iraq 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
MA - Marocco 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
SI - Slovenia 1
Totale 5.444
Salva come PNG Salva come JPEG
Città #
Chandler 488
Southend 448
Singapore 318
Dublin 209
Ashburn 173
Beijing 121
Jacksonville 100
Redmond 90
Wilmington 78
Lawrence 74
Princeton 74
Bologna 67
Ann Arbor 61
New York 60
Jinan 58
Shenyang 54
Verona 50
Nanjing 46
Sindelfingen 46
Helsinki 43
Tokyo 36
Woodbridge 35
Hebei 34
Seattle 33
Tianjin 28
Lomé 27
Washington 27
Zhengzhou 26
Taiyuan 22
Changsha 21
Haikou 21
Hangzhou 20
Ningbo 19
Moscow 18
Guangzhou 17
Houston 17
Nanchang 17
Dongguan 16
Fairfield 15
Jiaxing 15
Redwood City 15
Santa Clara 15
Dallas 14
Milan 13
Taizhou 13
San Francisco 12
Jakarta 11
Norwalk 11
Seoul 11
Venice 11
Falls Church 8
Fuzhou 8
Miami 8
Rome 8
Vienna 8
Brussels 7
Dearborn 7
Los Angeles 7
Amsterdam 6
Hong Kong 6
Lanzhou 6
Boydton 5
Chicago 5
Dong Ket 5
Düsseldorf 5
Kent 5
Munich 5
Shanghai 5
Bari 4
Easton 4
Esslingen am Neckar 4
Falkenstein 4
Lappeenranta 4
London 4
Renton 4
Toronto 4
Zurich 4
Biandronno 3
Cerea 3
Detroit 3
Faenza 3
Luino 3
Mehlingen 3
Nürnberg 3
Ottawa 3
Padova 3
São Paulo 3
Acquaviva Picena 2
Ardabil 2
Bandung 2
Bergamo 2
Bratislava 2
Calais 2
Campobasso 2
Cascina 2
Chapel Hill 2
Chennai 2
Chiampo 2
Hanoi 2
Isola della Scala 2
Totale 3.454
Salva come PNG Salva come JPEG
Nome #
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 150
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 123
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 121
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 119
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 111
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 106
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 105
Anti-CCP antibodies and bone 104
Safety issues and adverse reactions with osteoporosis management 100
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 100
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 99
Could γ\δ T-cells explain zoledronic acid adverse events? 98
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 97
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 90
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 90
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 90
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 87
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 86
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 84
Rheumatoid arthritis, γδ T cells and bisphosphonates 83
The obesity paradox and osteoporosis 82
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 75
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 73
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 73
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 72
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 72
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 71
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 70
Association between environmental air pollution and rheumatoid arthritis flares 70
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 69
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 67
Correction to: The obesity paradox and osteoporosis 65
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 64
Osteoporosis in Rheumatic Diseases 61
Calcium and vitamin D supplementation: when and why 61
Gender disparity in authorship of guidelines and recommendations in rheumatology 58
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 58
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 58
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 58
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 56
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 55
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 54
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 54
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 52
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 52
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 51
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 51
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 51
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 51
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 50
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 50
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 50
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 49
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 48
A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study 48
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 48
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3 47
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 47
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 45
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis 44
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 43
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 42
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 41
A Prospective Open-Label Observational Study of a Buffered Soluble 70{\hspace{0.167em}}mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The {GastroPASS} Study 40
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 38
Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart 37
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 36
Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial 35
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 34
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 33
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 33
Glucocorticoid-induced osteoporosis: 2019 concise clinical review 32
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 31
Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study 31
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 30
Association between acute exposure to environmental air pollution and fragility hip fractures 30
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 30
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 29
Cardiovascular Safety of Romosozumab: New Insights from Postmenopausal Women with Chronic Kidney Disease 28
Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis 28
Glucocorticoid-induced osteoporosis update 27
Pragmatic Clinical Trials in Osteoporosis 27
Bone loss occurs in Inflammatory Rheumatic Musculoskeletal Diseases (iRMD) patients treated with low dose glucocorticoids, but is prevented by anti-osteoporosis medications 26
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 26
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 25
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 25
Bone health status evaluation in men by means of REMS technology 23
Balancing benefits and risks in the era of biologics 22
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 22
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 20
Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting 20
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal 19
Regulation of bone mass in inflammatory diseases 18
Response to: ‘Correspondence on ‘Gender disparity in authorship of guidelines and recommendations in rheumatology’’ by Stewart et al 18
Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on 'Diagnosis, risk stratification, and continuity of care of fragility fractures' based on a systematic literature review 16
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 16
Machine learning to characterize bone biomarkers profile in rheumatoid arthritis 15
Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021 15
Changes in bone turnover markers and bone modulators during abatacept treatment 15
Providing high-quality care remotely to patients with rare bone diseases during COVID-19 pandemic 15
Totale 5.464
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.039
article - articoli 26.039
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.078
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020273 0 0 0 0 39 50 37 6 36 24 28 53
2020/2021656 96 132 22 114 58 44 40 5 52 5 55 33
2021/2022579 59 129 8 20 30 21 15 34 56 20 27 160
2022/20231.499 88 151 118 286 127 345 15 68 170 36 74 21
2023/2024982 40 70 89 125 80 202 54 44 30 43 151 54
2024/2025893 111 132 104 409 137 0 0 0 0 0 0 0
Totale 5.648